{"id":695,"date":"2004-02-26T00:00:00","date_gmt":"2007-04-09T11:12:53","guid":{"rendered":""},"modified":"2022-09-25T21:26:43","modified_gmt":"2022-09-26T01:26:43","slug":"global-access-to-medicines-will-canada-meet-the-challenge-a-submission-to-the-standing-committee-on-industry-science-and-technology-regarding-bill-c-9-an-act-to-amend-the-patent-act-and-the-food","status":"publish","type":"publication22","link":"https:\/\/www.hivlegalnetwork.ca\/site\/global-access-to-medicines-will-canada-meet-the-challenge-a-submission-to-the-standing-committee-on-industry-science-and-technology-regarding-bill-c-9-an-act-to-amend-the-patent-act-and-the-food\/","title":{"rendered":"Global Access to Medicines: Will Canada Meet the Challenge? &#8211; A Submission to the Standing Committee on Industry, Science and Technology regarding Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act"},"content":{"rendered":"Bill C-9 is Canada&#8217;s legislation to implement the WTO General Council Decision of 30 August 2003. The bill, therefore, should fully reflect the flexibility that the WTO Decision creates for countries to use compulsory licensing to import cheaper, generic phramaceutical products.<br \/>\n<!-- Jean Chr\u00e9tien Pledge to Africa, Bill C-9, patent, Patent Act, Food and Drugs Act, compulsory licensing, export, developing countries, right of first refusal, generic, manufacturer, producer, pharmaceutical, product, access to medicines, World Trade Organization, Doha Declaration, Decision of 30 August 2003, August 30, 2003 Decision, TRIPS, Agreement on Trade-Related Aspects of Intellectual Property Rights, Standing Committee on Industry, Science and Technology, House of Commons, Parliament, Right to health, Schedule 1 --><p class=\"download-link-button\"><a class=\"download-link en\" title=\"Global Access to Medicines: Will Canada Meet the Challenge? \u2013 A Submission to the Standing Committee on Industry, Science and Technology regarding Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act\" href=\"https:\/\/www.hivlegalnetwork.ca\/site\/download\/9904\/?tmstv=1777610748\" rel=\"nofollow\">\r\n\tDownload<\/a><\/p>","protected":false},"author":1,"featured_media":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"publication_topics":[145],"publication_type":[170],"publication_language":[184,185],"class_list":["post-695","publication22","type-publication22","status-publish","hentry","publication_topics-access-to-medicines","publication_type-advocacy","publication_language-english","publication_language-french"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/695","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22"}],"about":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/types\/publication22"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":6,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/695\/revisions"}],"predecessor-version":[{"id":20754,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/695\/revisions\/20754"}],"wp:attachment":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/media?parent=695"}],"wp:term":[{"taxonomy":"publication_topics","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_topics?post=695"},{"taxonomy":"publication_type","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_type?post=695"},{"taxonomy":"publication_language","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_language?post=695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}